Skip to main content

Want a detailed portfolio tracker?

BeiGene (ONC) P/E (2016 - 2026)

BeiGene (ONC) P/E from Feb 3, 2016 to Jul 21, 2026. The TTM BeiGene (ONC) P/E is 71.20. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of BeiGene (ONC)

YearP/EChange
202671.20-40.86%
2025120.39-500.64%
2024-30.05+54.37%
2023-19.47+88.53%
2022-10.33-41.20%
2021-17.56+29.35%
2020-13.58+29.01%
2019-10.52-9.99%
2018-11.69-85.63%
2017-81.35+799.81%
2016-9.04N/A

Comparison BeiGene (ONC) P/E with competitors

BeiGene (ONC) P/E is 71.20.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-99.99%
ENLVEnlivex Ltd0.07-99.89%
FGENFibroGen Inc0.24-99.66%
CHRSCoherus Biosciences Inc0.85-98.81%
FBIOFortress Biotech Inc0.95-98.67%
ORMPOramed Pharmaceuticals Inc1.50-97.89%
AGENAgenus Inc3.01-95.77%
INVAInnoviva Inc3.15-95.57%
VXRTVaxart Inc3.55-95.01%
CRMDCorMedix Inc3.63-94.90%
CVACCureVac N.V.4.45-93.76%
GLPGGalapagos NV4.86-93.18%
SRPTSarepta Therapeutics Inc4.88-93.14%
ABEOAbeona Therapeutics Inc5.39-92.43%
ABUSArbutus Biopharma Corp5.60-92.14%
ZVRAZevra Therapeutics Inc5.89-91.73%
SPROSpero Therapeutics Inc6.23-91.25%
CGENCompugen Ltd6.31-91.13%
RIGLRigel Pharmaceuticals6.87-90.35%
SLXNSilexion Therapeutics Corp7.30-89.75%
AUPHAurinia Pharmaceuticals Inc9.58-86.54%
PLXProtalix BioTherapeutics Inc10.89-84.70%
ACADAcadia Pharmaceuticals Inc11.73-83.53%
TBPHTheravance Biopharma Inc12.26-82.78%
ADMAAdma Biologics Inc12.42-82.56%
HRMYHarmony Biosciences Holdings Inc13.82-80.59%
SABSSAB Biotherapeutics Inc14.14-80.15%
NAGENiagen Bioscience Inc14.82-79.19%
INCYIncyte Corp15.82-77.78%
REGNRegeneron Pharmaceuticals Inc15.86-77.73%
PBYIPuma Biotechnology Inc17.32-75.68%
CPRXCatalyst Pharmaceuticals Inc17.44-75.51%
EXELExelixis Inc17.54-75.37%
TGTXTG Therapeutics Inc18.97-73.36%
MDXGMimedx Group Inc20.55-71.13%
XOMAXOMA Royalty Corp22.87-67.87%
ARGXArgen X SE24.30-65.87%
CTMXCytomX Therapeutics Inc24.82-65.14%
XOMAOXOMA Royalty Corp25.34-64.40%
HALOHalozyme Therapeutics Inc25.62-64.01%
XOMAPXOMA Royalty Corp25.67-63.95%
VRTXVertex Pharmaceuticals Inc27.99-60.68%
RPRXRoyalty Pharma plc - Class A28.69-59.71%
SLNOSoleno Therapeutics Inc29.02-59.25%
ASNDAscendis Pharma A/S30.09-57.74%
LGNDLigand Pharmaceuticals Inc - Class B37.91-46.75%
APLSApellis Pharmaceuticals Inc39.02-45.19%
BMRNBiomarin Pharmaceutical Inc42.21-40.71%
KRYSKrystal Biotech Inc45.34-36.31%
PHARPharming Group N.V.75.03+5.37%
TECHBio-Techne Corp101.96+43.20%
VCELVericel Corp109.92+54.39%
ALNYAlnylam Pharmaceuticals Inc117.96+65.68%
GMABGenmab140.29+97.04%
TLXTelix Pharmaceuticals Ltd162.15+127.74%
CORTCorcept Therapeutics Inc212.86+198.96%